Joon-Young Kim Selected Research

Joon-Young Kim Research Topics

Disease

4	Vascular Calcification 01/2016 - 04/2010
3	Atherosclerosis 11/2015 - 04/2009
3	Vascular System Injuries 01/2014 - 04/2009
3	Hyperplasia 01/2014 - 10/2009
3	Neoplasms (Cancer) 01/2013 - 03/2007
2	Glaucoma 07/2021 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 02/2012
2	Fibrosis (Cirrhosis) 02/2012 - 01/2012
2	Intervertebral Disc Displacement (Herniated Disc) 01/2010 - 07/2007
1	Blister (Bulla) 07/2021
1	Fistula 01/2021
1	Vascular Remodeling 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Vascular Diseases (Vascular Disease) 01/2014
1	Cerebral Palsy (Spastic Diplegia) 07/2013
1	Neonatal Jaundice 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Ureteral Obstruction 01/2012
1	Urolithiasis 05/2011
1	Hypercalciuria 05/2011
1	Infections 11/2010
1	Thrombosis (Thrombus) 11/2010
1	Type 2 Diabetes Mellitus (MODY) 04/2010
1	Back Pain (Backache) 01/2010
1	Carcinogenesis 10/2008
1	Body Weight (Weight, Body) 07/2004
1	Familial Hypoadrenocorticism 05/2004
1	Dosage-sensitive sex reversal 05/2004

Drug/Important Bio-Agent (IBA)

2	CollagenIBA 07/2021 - 01/2018
2	pyruvate dehydrogenase kinase 4IBA 01/2016 - 11/2015
2	Phosphates (Orthophosphate)IBA 11/2015 - 02/2012
2	quinone (benzoquinone)IBA 01/2014 - 04/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2014 - 04/2009
2	Dimethyl FumarateIBA 01/2014 - 01/2012
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2013 - 10/2008
2	Collagen Type I (Type I Collagen)IBA 02/2012 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012 - 01/2012
2	AntioxidantsIBA 02/2012 - 11/2010
2	Thioctic Acid (Lipoic Acid)IBA 02/2012 - 11/2010
1	collagen-glycosaminoglycan copolymerIBA 07/2021
1	Ophthalmic Solutions (Eye Drops)IBA 07/2021
1	Contrast MediaIBA 01/2021
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 11/2015
1	CalciumIBA 11/2015
1	Pharmaceutical PreparationsIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	NF-E2-Related Factor 2IBA 01/2014
1	scoparoneIBA 01/2013
1	AgarIBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Caspase 9IBA 02/2012
1	sulforaphaneIBA 02/2012
1	Cytochromes c (Cytochrome c)IBA 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	Genetic Markers (Genetic Marker)IBA 05/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2011
1	Calcium OxalateIBA 05/2011
1	Calcium-Sensing ReceptorsIBA 05/2011
1	p38 Mitogen-Activated Protein KinasesIBA 11/2010
1	RNA (Ribonucleic Acid)IBA 11/2010
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 04/2010
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 04/2010
1	OsteoprotegerinIBA 04/2010
1	ClusterinIBA 10/2009
1	PyransIBA 04/2009
1	NAD (NADH)IBA 04/2009
1	beta-lapachoneIBA 04/2009
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	Serine (L-Serine)FDA Link 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	Oxygen (Dioxygen)IBA 07/2007
1	OzoneIBA 07/2007
1	cyclopentenoneIBA 03/2007
1	Estrogen Receptor alphaIBA 03/2007
1	PPAR gammaIBA 03/2007
1	NucleotidesIBA 07/2004
1	Amino Acids FDA Link 05/2004
1	Orphan Nuclear ReceptorsIBA 05/2004

Therapy/Procedure

2	Therapeutics 04/2009 - 07/2007
1	Osteotomy 07/2013
1	Ligation 02/2012
1	Stents 11/2010
1	Drug-Eluting Stents 11/2010
1	Electroacupuncture 01/2010
1	Aftercare (After-Treatment) 07/2007